CSPC PHARMACEUT.GR. ADR4 (CVGU) — Cash Flow Quality Index
CSPC PHARMACEUT.GR. ADR4 (CVGU) has a Cash Flow Quality Index of 1.50x as of December 2025. Operating cash flow of €5.83 Billion exceeds net income of €3.88 Billion, indicating high earnings quality where cash backs reported profits. Explore CSPC PHARMACEUT.GR. ADR4 (CVGU) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
CSPC PHARMACEUT.GR. ADR4 Cash Flow Quality Index (2021–2025)
Historical Cash Flow Quality Index for CSPC PHARMACEUT.GR. ADR4 across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash flow conversion of CSPC PHARMACEUT.GR. ADR4.
Annual Cash Flow Quality Index for CSPC PHARMACEUT.GR. ADR4 (2021–2025)
Year-by-year earnings quality comparison for CSPC PHARMACEUT.GR. ADR4.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.50x | €5.83 Billion | €3.88 Billion | ▲ +53.4% |
| 2024 | 0.98x | €4.53 Billion | €4.63 Billion | ▲ +49.5% |
| 2023 | 0.65x | €4.18 Billion | €6.38 Billion | ▼ -40.3% |
| 2022 | 1.10x | €7.63 Billion | €6.95 Billion | ▲ +63.4% |
| 2021 | 0.67x | €4.64 Billion | €6.90 Billion | — |